Overview

Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
To determine the safety of Alimta when used with chemoradiation in inoperable non small cell lung cancer
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Collaborator:
Eli Lilly and Company
Treatments:
Carboplatin
Pemetrexed